Filter This View

  • Mylan Inc. v. Comm'r of Internal Revenue

    Publication Date: 2023-08-14
    Practice Area: Tax
    Industry: Federal Government | Manufacturing | Pharmaceuticals
    Court: U.S. Court of Appeals for the Third Circuit
    Judge: Judge Jordan
    Attorneys: For plaintiff: Clint Carpenter, Arthur T. Catterall, United States Department of Justice Tax Division, Washington, DC; Emily J. Giometti, Cincinnati, OH; Lisa M. Rodriguez, Office of District Council, Internal Revenue Service, Newark, NJ; Mary H. Weber, Internal Revenue Service Office of Chief Counsel, Cincinnati, OH for appellant.
    for defendant: Gregory G. Garre, Eric Konopka, Latham & Watkins, Washington, DC; Bryan M. Killian, William F. Nelson, James G. Steele, III, Morgan Lewis & Bockius, Washington, DC for appellee.
    Case Number: 22-1193

    Legal expenses incurred by generic drug manufacturers to defend against patent infringement lawsuits were tax-deductible where they were ordinary and necessary business expenses as patent litigation was separate from the FDA approval process for ANDAs.

  • May 23, 2012 | Daily Business Review

    Judge Jordan praised for 'nice guy' style

    Chief U.S. District Judge Federico Moreno loves to squirrel away stories about his fellow judges for special occasions: investitures, honors, cocktail parties. Moreno spoke at a Univer

    1 minute read

  • May 21, 2012 | Daily Business Review

    Judge Adalberto Jordan: The case of a nice guy finishing first

    Chief U.S. District Judge Federico Moreno loves to squirrel away stories about his fellow judges for special occasions: investitures, honors, cocktail parties. Moreno spoke at a Univer

    1 minute read

  • December 9, 2002 | New Jersey Law Journal

    The Distasteful

    Medicine of De-Equitization AMERICAN LAWYER MEDIA De-equitization. It seems like a harmless enough word. But for managing partners, it's seemingl

    1 minute read

  • December 5, 2002 | The Legal Intelligencer

    The Distasteful Medicine of De-Equitization

    De-equitization. It seems a harmless enough word. But for managing partners, it's seemingly even less popular than the ultimate conversation kryptonite: layoff.That doesn't change the

    1 minute read